TABLE 5

Assessment of asthma control

Country/organisationFirst author [ref.]Daytime symptomsActivity limitationsNocturnal symptomsMild symptomsApparent symptomsNeed for reliever medicationPEF or FEV1ExacerbationACT/ACQMedication side-effectsAsthma diaryOther programmes/toolsAbsence from work or school due to asthma
CanadaLougheed [15]YesYesYesNANANAYesYesNANANANAYes
Latin America and SpainRodrigo [28]YesYesYesNANAYesYesYesNoNoNoNoNA
ICON Pediatric AsthmaPapadopoulos [16]YesYesYesNANAYesYesYesNAYesNANANA
South AfricaKling [17]NANANANANANANANANANANANANA
KoreaKim [18]NANANANANANANANANANANANANA
IndiaAgarwal [15]YesYesYesNANANAYesNANANANANANA
JapanArakawa [20]NAYesNAYesYesYesNANAYesNAYesJPACNA
New ZealandAsher [21]YesYesYesNANAYesNANANANANANANA
GermanyBuhl [29]YesYesYesYesYesYesYesYesYesNANANANA
SpainExecutive Committee GEMA [22]YesYesYesNANAYesYesYesNAYesNAYesNA
ItalyIndinnimeo [23]NANANANANANANANANANANANANA
SwitzerlandRothe [24]YesNAYesYesNAYesYesYesNAYesNANANA
UKScottish Intercollegiate Guidelines Network, British Thoracic Society [25]NANANANANAYesYesYesYesNANANANA
GINAGlobal Initiative for Asthma [1]YesYesYesNANAYesYesYesYesYesNANANA
FranceLe Conte [26]NANANANANANANANANANANANANA
Saudi ArabiaAl-Moamary [27]NANANANANANANANANANANANANA

PEF: peak expiratory flow; FEV1: forced expiratory volume in 1 s; ACT: Asthma Control Test; ACQ: Asthma Control Questionnaire; NA: not available; ICON: International Consensus On; GEMA: Guia Espanola para el Manejo del Asma; GINA: Global Initiative for Asthma; JPAC: Japanese Pediatric Asthma Control Program.